2012
DOI: 10.1016/j.ymeth.2012.05.008
|View full text |Cite
|
Sign up to set email alerts
|

Mass spectrometry approaches to monitor protein–drug interactions

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

0
22
0

Year Published

2012
2012
2017
2017

Publication Types

Select...
6
3
1

Relationship

0
10

Authors

Journals

citations
Cited by 24 publications
(23 citation statements)
references
References 141 publications
(162 reference statements)
0
22
0
Order By: Relevance
“…Establishing SILAC-qGAP-Quantitative affinity purification combined with mass spectrometry can be used to study cellular dynamics of PPIs (8,9,(11)(12)(13). The principle is to compare the abundance of proteins copurifying with the bait to an internal control.…”
Section: Resultsmentioning
confidence: 99%
“…Establishing SILAC-qGAP-Quantitative affinity purification combined with mass spectrometry can be used to study cellular dynamics of PPIs (8,9,(11)(12)(13). The principle is to compare the abundance of proteins copurifying with the bait to an internal control.…”
Section: Resultsmentioning
confidence: 99%
“…values of h xy for HMBA + AA system in D-mannitol solutions are all positive due to the dominance of the partial desolvation and hydrophobic interactions over H-bonding interactions. (2) The values of h xy for HMBA + AA system follow the order h xy (glycine) < h xy (L-serine) < h xy (L-alanine) because of the structural difference of the three amino acids. (3) With the increasing D-mannitol molar fraction, the h xy values of HMBA with the three amino acids all pass through a maximum at about 0.0018 molar fraction of D-mannitol, which is caused by the compensation of the endothermic dehydration effect and the exothermic H-bonding effect.…”
Section: Resultsmentioning
confidence: 99%
“…To circumvent this limitation, approaches for systematically identifying drug-target interactions are increasingly being used. These include mass spectrometry-based methods (see [31]), phage display and protein microarray approaches, as well as technologies that provide more global information, such as drug-induced changes in mRNA or protein levels, or metabolite expression profiles [18].…”
Section: Investigating Drug-protein Interactions: the Yeast Threehybrmentioning
confidence: 99%